| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 仰佳佳 | 申万宏源 | 医药生物 | 33.40% | 41.75% | 27.01% | 23.08% | 1 | -37.64% | 2025-05-22 |
| 2 | 王斌 | 首创证券 | 医药生物 | 33.18% | 37.20% | 20.27% | 4.11% | 19 | -54.62% | 2025-07-23 |
| 3 | 阳景 | 浦银国际证券 | 医药生物 | 33.18% | 27.06% | 13.76% | 100.00% | 4 | 0.00% | 2025-06-11 |
| 4 | 吴春红 | 江海证券 | 医药生物 | 33.18% | 18.09% | 25.86% | 27.27% | 7 | -25.67% | 2025-05-16 |
| 5 | 华挺 | 财通证券 | 医药生物 | 33.18% | 26.50% | 19.20% | -6.67% | 4 | -50.33% | 2025-06-12 |
| 6 | 阳景 | 浦银国际证券 | 医药生物 | 33.17% | 31.73% | 8.48% | 100.00% | 4 | 0.00% | 2025-06-25 |
| 7 | 张林晚 | 上海证券 | 医药生物 | 33.17% | 37.80% | 21.29% | -100.00% | 1 | -18.93% | 2025-07-04 |
| 8 | 武煜 | 招银国际 | 医药生物 | 33.07% | 27.69% | 20.01% | -33.33% | 2 | -16.66% | 2025-06-04 |
| 9 | 袁聪敏 | 中信证券 | 医药生物 | 33.06% | 26.63% | 24.76% | 100.00% | 5 | 0.00% | 2025-04-21 |
| 10 | 袁聪敏 | 中信证券 | 医药生物 | 33.05% | 26.62% | 25.19% | 100.00% | 5 | 0.00% | 2025-04-24 |
| 11 | 仰佳佳 | 申万宏源 | 医药生物 | 33.02% | 36.23% | 32.93% | 23.08% | 3 | -37.64% | 2025-04-28 |
| 12 | 唐寅灏 | 中信证券 | 医药生物 | 32.96% | 28.69% | 26.64% | 85.71% | 12 | -8.47% | 2025-05-23 |
| 13 | 李蔚 | 中航证券 | 医药生物 | 32.83% | 37.06% | 31.72% | 14.29% | 7 | -49.52% | 2025-08-01 |
| 14 | 仰佳佳 | 申万宏源 | 医药生物 | 32.81% | 39.11% | 5.59% | 23.08% | 1 | -37.64% | 2025-07-16 |
| 15 | 阳景 | 浦银国际证券 | 医药生物 | 32.77% | 23.90% | 9.56% | 100.00% | 4 | 0.00% | 2025-06-09 |
| 16 | 武煜 | 招银国际 | 医药生物 | 32.75% | 32.81% | 19.54% | -33.33% | 2 | -16.66% | 2025-05-29 |
| 17 | 张林晚 | 上海证券 | 医药生物 | 32.69% | 34.32% | 24.45% | -100.00% | 1 | -18.93% | 2025-07-25 |
| 18 | 阳景 | 浦银国际证券 | 医药生物 | 32.61% | 39.37% | 3.34% | 100.00% | 4 | 0.00% | 2025-07-04 |
| 19 | 仰佳佳 | 申万宏源 | 医药生物 | 32.52% | 34.01% | 33.47% | 23.08% | 4 | -37.64% | 2025-04-24 |
| 20 | 阳景 | 浦银国际证券 | 医药生物 | 32.41% | 39.16% | 3.18% | 100.00% | 4 | 0.00% | 2025-07-03 |